Finally, we tested whether Rac1 inhibition is able to improve endothelial function of portions of saphenous veins used as conduits for surgical revascularization (bypass) of patients with peripheral ischemia due to severe artery disease (Table). This evidence concerns the gene RAC1 and arterial disorder.